RNF7 and cancer: The homozygous amplification of RBX2, had a significant proportion in some specific cancers containing CESC, ESCA, HNSC, LUSC and OV, for example, RBX2 homozygous amplification in LUSC was accounted for about 20% (Figure 5A).